Related Experiment Video
Updated: Jun 13, 2026
Labeling hESCs and hMSCs with Iron Oxide Nanoparticles for Non-Invasive in vivo Tracking with MR Imaging
Published on: March 31, 2008
Advances in cardiovascular molecular imaging for tracking stem cell therapy
Katherine J Ransohoff1, Joseph C Wu
1Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305-5324, USA. joewu@stanford.edu
Insights
Cardiovascular disease mortality is high due to poor heart repair. Stem cell therapy shows promise, but its mechanisms require advanced imaging techniques for investigation.
Area of Science:
- Regenerative Medicine
- Cardiovascular Science
- Medical Imaging
Background:
- Cardiovascular disease leads to high mortality, partly because the heart lacks cells that can proliferate to repair damage.
- Myocardial infarction (heart attack) can cause progressive dilation and heart failure if not adequately repaired.
- Stem cell therapy is a potential treatment for cardiovascular disease, but its precise benefits and mechanisms are not fully understood.
Purpose of the Study:
- To review the principles, techniques, applications, and limitations of multi-modality molecular imaging for investigating stem cell therapy in cardiovascular disease.
- To highlight the importance of advanced imaging technologies for understanding stem cell biology before clinical application.
Main Methods:
- Discussion of four key molecular imaging modalities: radionuclide imaging, magnetic resonance imaging (MRI), bioluminescence imaging (BLI), and fluorescence imaging (FI).
- Exploration of basic principles and labeling techniques specific to each imaging modality for tracking stem cells.
- Review of current and potential clinical applications of these imaging techniques in cardiovascular research.
Main Results:
- Each imaging modality offers unique advantages and disadvantages for visualizing stem cell behavior in the heart.
- Radionuclide imaging provides high sensitivity, while MRI offers excellent spatial resolution.
- BLI and FI are valuable for preclinical research, offering different spectral ranges and penetration depths.
Conclusions:
- Multi-modality molecular imaging is crucial for elucidating the mechanisms of stem cell therapy in cardiovascular disease.
- Understanding the strengths and weaknesses of each imaging technique is essential for selecting the appropriate method for specific research questions.
- Further development and application of these imaging technologies will accelerate the safe and effective translation of stem cell therapies for heart conditions.
Abstract:
The high mortality rate associated with cardiovascular disease is partially due to the lack of proliferative cells in the heart. Without adequate repair following myocardial infarction, progressive dilation can lead to heart failure. Stem cell therapies present one promising option for treating cardiovascular disease, though the specific mechanisms by which they benefit the heart remain unclear. Before stem cell therapies can be used safely in human populations, their biology must be investigated using innovative technologies such as multi-modality molecular imaging. The present review will discuss the basic principles, labelling techniques, clinical applications, and drawbacks associated with four major modalities: radionuclide imaging, magnetic resonance imaging, bioluminescence imaging, and fluorescence imaging.
